Replies to post #371213 on Anavex Life Sciences Corp (AVXL)

[MayoMobile]

I agree. Strong P-values and Cohens-D effect sizes should be expected from the 509 patient trial. I too would have concerns if this was not the case.

Obviously, we should see greater efficacy in a dose dependent manner.